Intellipharmaceutics International Price Prediction
| IPCIFDelisted Stock | USD 0.04 0.00 0.00% |
Oversold Vs Overbought
53
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Intellipharmaceutics based on different types of headlines from major news networks to social media. Using Intellipharmaceutics hype-based prediction, you can estimate the value of Intellipharmaceutics International from the perspective of Intellipharmaceutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Intellipharmaceutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Intellipharmaceutics to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Intellipharmaceutics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Intellipharmaceutics after-hype prediction price | USD 0.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Intellipharmaceutics |
Intellipharmaceutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Intellipharmaceutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Intellipharmaceutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Intellipharmaceutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Intellipharmaceutics Estimiated After-Hype Price Volatility
In the context of predicting Intellipharmaceutics' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Intellipharmaceutics' historical news coverage. Intellipharmaceutics' after-hype downside and upside margins for the prediction period are 0.03 and 0.04, respectively. We have considered Intellipharmaceutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Intellipharmaceutics is very steady at this time. Analysis and calculation of next after-hype price of Intellipharmaceutics is based on 3 months time horizon.
Intellipharmaceutics OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Intellipharmaceutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Intellipharmaceutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Intellipharmaceutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.04 | 0.04 | 5.26 |
|
Intellipharmaceutics Hype Timeline
Intellipharmaceutics is currently traded for 0.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Intellipharmaceutics is forecasted to increase in value after the next headline, with the price projected to jump to 0.04 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is projected to be 5.26%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on Intellipharmaceutics is about 0.0%, with the expected price after the next announcement by competition of 0.04. Intellipharmaceutics International has accumulated about 79.65 K in cash with (2.46 M) of positive cash flow from operations. Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.Intellipharmaceutics Related Hype Analysis
Having access to credible news sources related to Intellipharmaceutics' direct competition is more important than ever and may enhance your ability to predict Intellipharmaceutics' future price movements. Getting to know how Intellipharmaceutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Intellipharmaceutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IGXT | Intelgenx Technologs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EMMA | Emmaus Life Sciences | 0.00 | 0 per month | 7.45 | (0) | 18.52 | (13.33) | 45.86 | |
| ASLN | Aslan Pharmaceuticals | (0.12) | 8 per month | 0.00 | (0.26) | 8.75 | (18.91) | 58.28 | |
| RGRX | Regenerx Biopharm In | 0.00 | 0 per month | 14.36 | 0.09 | 50.00 | (33.33) | 106.67 | |
| RSPI | RespireRx Pharmaceuticals | 0.00 | 0 per month | 12.21 | 0.08 | 34.62 | (21.57) | 76.50 |
Intellipharmaceutics Additional Predictive Modules
Most predictive techniques to examine Intellipharmaceutics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intellipharmaceutics using various technical indicators. When you analyze Intellipharmaceutics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Intellipharmaceutics Predictive Indicators
The successful prediction of Intellipharmaceutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Intellipharmaceutics International, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Intellipharmaceutics based on analysis of Intellipharmaceutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Intellipharmaceutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Intellipharmaceutics's related companies.
Story Coverage note for Intellipharmaceutics
The number of cover stories for Intellipharmaceutics depends on current market conditions and Intellipharmaceutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Intellipharmaceutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Intellipharmaceutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Intellipharmaceutics Short Properties
Intellipharmaceutics' future price predictability will typically decrease when Intellipharmaceutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Intellipharmaceutics International often depends not only on the future outlook of the potential Intellipharmaceutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intellipharmaceutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.1 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |